Michael Gruber, a managing partner at Salveo Capital, a cannabis-focused investment firm, said the Altria/Cronos deal could open the floodgates for similar deals, particularly as the U.S. market inches toward federal legalization.
Read More
Salveo Capital portfolio company, TILT Holdings Inc. (CSE:TILT), a vertically-integrated infrastructure and technology cannabis company, officially began trading on the Canadian Securities Exchange.
Read More
Salveo Capital, an alternative investment firm specializing in the legalized cannabis space, today announced it has acquired a minority equity interest in Ascend Wellness (“Ascend”), a vertically integrated multi-state operator in the cannabis industry.
Read More
Salveo Capital portfolio company, TILT, announced it has acquired two leading cannabis companies to expand its capabilities in the cultivation and logistics spaces. This announcement is the latest in a series of moves to expand TILT’s offerings for cannabis businesses and consumers.
Read More
Salveo Capital portfolio company, Front Range Biosciences, today announced that it signed a lease with Memorial Florists and Greenhouses Inc. for a Clean Stock® hemp nursery in Appleton, Wisconsin.
Read More
“Harborside, one of the most iconic and well-known brands in the cannabis industry, with an extensive and loyal customer base, is poised for significant expansion in the California market,” said Michael Gruber and Jeffrey Howard, Managing Partners at Salveo Capital.
Read More
Salveo Capital, an alternative investment firm specializing in the legalized cannabis space, today announced that it has completed an investment in Harborside, the iconic California-based vertically integrated cannabis company.
Read More
Michael Gruber and Jeffrey Howard, managing partners of Salveo Capital, a cannabis investment firm, also joined in the merriment but sounded a cautious note regarding Sessions’ replacement.
Read More
Mergers & Acquisitions asked Michael Gruber, managing partner at Salveo Capital, to share his thoughts on how the mid-term elections will affect M&A and the cannabis sector.
Read More
The Northbrook, Ill.-based firm has avoided investments in companies that touch the plant, but recent regulatory advances in the industry have encouraged the firm to reconsider its approach.
Read More
Canada has joined Uruguay to become the second country in the world to legalize pot. What does the new federal law mean for private equity? TBD. Marijuana legalization up north did give me a reason to check in with Salveo Capital – which invests not in growers but in underlying services like testing technology for cannabis labs – to hear their two cents.
Read More
To get a handle on who's cutting early-stage deals in the fledgling industry, Business Insider pulled data from PitchBook and reached out to the top venture-capital firms (including Salveo Capital) in the industry.
Read More
Chicago-based cannabis investment firm Salveo Capital has participated in a $10 million Series A round for Front Range Biosciences, a Colorado-headquartered company focused on tissue-culture propagation of high-value crops.
Read More
Leading agricultural biotech company (and a Salveo Capital portfolio company) closes largest ever U.S. cannabis biotech funding round.
Read More
Salveo Capital, an alternative investment firm specializing in the legalized cannabis space, today announced the formation of its Advisory Board comprised of a select group of professionals who will provide guidance to the firm on various strategic matters.
Read More
As the legalized pot industry continues to see explosive growth, Salveo Capital is moving quickly to capture the one segment of the market it has deemed underserved.
Read More
Salveo is participating in the funding round with firms that include Altitude Investment Management, Panther Opportunity Fund, Canopy Ventures, Tendaji Investments, PB Venture Group, Halley Venture Partners and FlatIron Group, according to a spokesman for Salveo.
Read More
With its cutting edge solutions and high quality products, PathogenDx represents an innovative and disruptive company that is changing the testing process for cannabis-related products as we know it,” said Jeffrey Howard, a Managing Partner at Salveo Capital. “We believe that as customers and growers continue to seek the
Read More
Canada's Canopy Growth Corp is buying Toyko Smoke cannabis owner Hiku Brands Co Ltd for C$269.2 million ($205.3 million), the latest deal in a fast-consolidating sector ahead of legal recreational marijuana sales.
Read More
The conventional wisdom on Wall Street is that it’s impossible to time the market. Venture capitalists, however, know all too well that when investing in either startup companies or nascent industries, timing is everything. Nowhere is this more true, today, than in the emerging cannabis market.
Read More